Brett Favre says he has Parkinson’s at congressional hearing on welfare fraud
Testifying Tuesday before the House Ways and Means Committee, Hall of Fame quarterback Brett Favre said in a prepared statement that he was recently diagnosed…
In praising Harris at Democratic convention, Hillary Clinton says ‘future is here’
1 of 21 | Former Secretary of State Hillary Clinton called on Americans on Monday to "fight for the truth and fight for Kamala, because…
6,000 police deployed as Brtiain braces for wave of riots targeting immigration lawyers
British authorities were gearing up for as many as 30 riots across the country Wednesday night amid fears the offices of law firms that represent…
Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal aging-related neurodegeneration, Parkinson’s disease, and Alzheimer’s disease
This section is Partnership Content suppliedThe content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its…